Efficacy of nifekalant hydrochloride on the treatment of life-threatening ventricular tachyarrhythmias during reperfusion for acute myocardial infarction

Cardiovascular Drugs and Therapy

Volumn 15, Issue 4, 2001, Pages 363-365

  Koizumi, Tomomi ^a   Komiyama, Nobuyuki ^a   Komuro, Issei ^a   Tanigawa, Takashi ^b   Iwase, Takashi ^b   Ishiwata, Sugao ^b   Nishiyama, Shin Ichirou ^b   Nakanishi, Shigemoto ^b   Momomura, Shin Ichi ^b  

^a CHIBA UNIVERSITY   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

Myocardial infarction; Nifekalant; Ventricular tachyarrhythmia

Indexed keywords

ANTIARRHYTHMIC AGENT; NIFEKALANT; POTASSIUM CHANNEL BLOCKING AGENT;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CASE REPORT; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY STENT; HEART MUSCLE REPERFUSION; HEART VENTRICLE TACHYCARDIA; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL; RIGHT CORONARY ARTERY; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-ARRHYTHMIA AGENTS; CORONARY ANGIOGRAPHY; ELECTRIC COUNTERSHOCK; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PYRIMIDINONES; STENTS; VENTRICULAR FIBRILLATION;

EID: 0035212270     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012723101831     Document Type: Article

References (5)

1. Effect of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocyte
2. IK-independent class III actions on MS-551 compared with sematilide and dofetilide during reperfusion in anesthetized rats
3. Antiarrhythmic agent, MS-551, protects against pinacidil + hypoxia-induced ventricular fibrillation in Langendorff-perfused rabbit isolated heart
4. Antiarrhythmic effect of MS-551, a new class III antiarrhythmic agent, on canine models of ventricular arrhythmia
5. Cellular electrophysiological effects of MS-551, a new class III antiarrhythmic agent, in various cardiac tissues: Comparison with d-sotalol